Successful Case

Pure Global earns 2 New Brazilian certificates

Pure Global Secures Two Class II Medical Device Certificates in Brazil, Bolstering International Expansion Capabilities.

Published on:
March 1, 2024

We're proud to announce that Pure Global has successfully obtained two certificates from Brazil for Class II products. These certifications are for interventional catheter consumables companies for medical device MDs in Suzhou and Shenzhen, respectively.

Our Brazilian self-operated companies boast a growing portfolio of certificates and satisfied customer groups. With a highly experienced technical team in Brazil, we maintain excellent communication channels with #ANVISA and offer years of rich registration expertise. This enables us to efficiently meet our customers' submission and certification requirements, ensuring a smooth process.

Pure Global is your professional registration consulting partner, guiding companies through international expansion with detailed expertise, efficient execution, and firsthand resources. Our success in Brazil underscores our ability to provide comprehensive consulting services and secure certifications for our clients.

At Pure Brazil, our commitment to service and professionalism shines through. As an independent third-party certificate holder, we prioritize customer needs, employing a dual PM work model to ensure timely responses. Our expert regulatory consulting team and self-operated companies maintain strong relationships with local representatives in Brazil, providing manufacturers with accurate and timely information on local regulations and authorities' feedback.

Trust Pure Global and Pure Brazil for seamless market access and regulatory compliance solutions!

Subscribe to newsletter
Subscribe to receive the latest blog posts to your inbox every week.
By subscribing, you agree to our Terms and Conditions.
Thank you for subscribing!
Oops! Something went wrong while submitting the form.
Read more

Latest News

Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.

Regulatory Update
March 6, 2025

In this week's update, we cover highlights from The EMDN Working Group's November 2024 meeting, which includes important developments in medical device nomenclature.

Regulatory Update
February 19, 2025

This week in global medical device news: Brazil's ANVISA goes 100% digital, more Approved Bodies in the UK, revised guidance on HIV self-test kits in Malaysia, and more.

Regulatory Update
February 12, 2025

The fifth revision to the EU's guidance on Notified Body requirements under the MDR and IVDR has been released. Canada published new guidance on machine learning-enabled devices, findings from China's Medical Device Standards Management Annual Report, and more in this week's round-up of medical device regulatory news.

Regulatory Update
February 5, 2025

To close out January 2025, we are reporting on medical device regulatory developments in the European Union and Switzerland, including IVDR compliance challenges cited in the MedTech Europe 2024 Regulatory Survey, as well as guidance, FAQ, and form updates from Swissmedic.

Contact us
Request information

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Our closest representative will get back to you within 24 hours.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Latest Blog Content

Explore our collection of articles, success stories, and regulatory updates, designed to help you take your product global.

RIVM report: The impact of the new European IVD-classification rules on notified body involvement A study on IVDs registered in the Netherlands
Blog Article

The IVDR transition includes structured processes IVD manufacturers must follow to engage with Notified Bodies. Many IVD manufacturers are interacting with Notified Bodies for the first time and must understand what is required to ensure a successful partnership. In this article, Dr. Oliver Eikenberg clarifies what manufacturers must prepare and when to engage a Notified Body for IVDR CE Marking.

Blog Article

Class D IVD manufacturers face fast-approaching IVDR transition deadlines, though some are more familiar with the regulatory process. In this article, Dr. Oliver Eikenberg discusses the difference between "new" and "old" Class Ds, and regulatory logistics they need to consider during the transition process.

Blog Article

Your IVD's intended purpose determines its classification, clinical evidence requirements, and clinical applications under the IVDR. Device companies will need a more robust intended purpose to fulfill IVDR criteria. In this article, Dr. Oliver Eikenberg explains the role of the intended purpose in IVDR compliance.

Blog Article

Many IVD and legacy IVD device manufacturers are obligated to comply with certain aspects of the IVDR even before their transition deadline. In this article, Oliver Eikenberg discusses how IVD companies can maintain EU compliance during the transition period.